Melanie Doupé Gaiser, Ph.D., M.P.H., M.A.

home / authors / melanie-doup-gaiser-ph-d-m-p-h-m-a-

Melanie Doupé Gaiser, Ph.D., M.P.H., M.A., is a vice president in Ruder Finn’s Healthcare practice and has expertise in both health policy and payer issues. Previously, Gaiser led health services research.

Articles

Image credit: ©jirsak stock.adobe.com

Building Trust and Shaping Perception: Turning Industry Challenges into Health Plan Opportunities

Melanie Doupé Gaiser, Ph.D., M.P.H., M.A.
January 22nd 2024

Read More

Latest Updated Articles

man looking at screen with gene images | ©muhammad stock.adobe.com
Published: December 10th 2024 | Updated: December 24th 2024
Next-Generation Testing Cheaper and More Effective for Guiding Lung Cancer Treatment
Pills balancing on top of each other | Image credit: James Thew - stock.adobe.com
Published: July 20th 2020 | Updated: December 24th 2024
For Better HCQ Retinopathy Guidelines, Include Prescribing Physicians
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
Published: October 3rd 2024 | Updated: December 24th 2024
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
Published: October 7th 2024 | Updated: December 24th 2024
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
Published: November 7th 2024 | Updated: December 24th 2024
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
Published: July 11th 2024 | Updated: December 24th 2024
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
© 2024 MJH Life Sciences

All rights reserved.